Pliant Therapeutics Inc
PLRX
Market Cap$78.57M
Close$
$0.18
86% downside
Current Fair Value
86% downsideOvervalued by 86% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $78.57 Million |
|---|---|
| Enterprise Value | $46.81 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.47 |
| Beta | 1.36 |
| Outstanding Shares | 61,222,676 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.36 |
|---|---|
| PEG | -1.82 |
| Price to Sales | - |
| Price to Book Ratio | 0.33 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.2 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.29 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Pliant Therapeutics Inc
CEO: Bernard Coulie